Hypercell Technologies
Atlanta
About Hypercell Technologies
Hypercell Technologies develops tools to control infectious diseases in animals. Hypercell believes that the best chance to stop a future pandemic in humans is to prevent it by proactively controlling viruses in production animal reservoirs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: hypercelltechnologies.com
- Phone: (001) 404 - 661 - 8856
Industries & Categories
Biotechnology, Life Science, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/hypercell-technologies-36236 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.